A detailed history of State Of Wisconsin Investment Board transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 369,996 shares of AUPH stock, worth $3.34 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
369,996
Previous 416,928 11.26%
Holding current value
$3.34 Million
Previous $2.38 Million 13.95%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.32 - $7.33 $249,678 - $344,011
-46,932 Reduced 11.26%
369,996 $2.71 Million
Q2 2024

Aug 14, 2024

SELL
$4.81 - $5.78 $95,978 - $115,334
-19,954 Reduced 4.57%
416,928 $2.38 Million
Q1 2024

May 14, 2024

BUY
$4.93 - $9.31 $817,014 - $1.54 Million
165,723 Added 61.12%
436,882 $2.19 Million
Q4 2023

Feb 12, 2024

BUY
$7.13 - $9.49 $1.18 Million - $1.57 Million
165,882 Added 157.57%
271,159 $2.44 Million
Q3 2023

Nov 14, 2023

SELL
$7.77 - $12.27 $59,790 - $94,417
-7,695 Reduced 6.81%
105,277 $818,000
Q2 2023

Aug 14, 2023

BUY
$8.96 - $11.69 $13,735 - $17,920
1,533 Added 1.38%
112,972 $1.09 Million
Q1 2023

May 15, 2023

SELL
$5.94 - $11.27 $36,269 - $68,814
-6,106 Reduced 5.19%
111,439 $1.22 Million
Q4 2022

Feb 14, 2023

BUY
$4.11 - $8.14 $15,502 - $30,704
3,772 Added 3.32%
117,545 $507,000
Q3 2022

Nov 14, 2022

SELL
$6.66 - $12.39 $32,154 - $59,818
-4,828 Reduced 4.07%
113,773 $856,000
Q2 2022

Aug 15, 2022

BUY
$8.95 - $12.8 $244,343 - $349,452
27,301 Added 29.9%
118,601 $1.19 Million
Q1 2022

May 13, 2022

BUY
$10.05 - $22.48 $917,565 - $2.05 Million
91,300 New
91,300 $1.13 Million

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.28B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.